Analysis of the reactions used for the preparation of drug candidate molecules.

The purpose of this perspective is to indicate the range of chemistries used in the manufacture of drug candidate molecules and to highlight certain gaps in current technologies. To do this a survey was carried out of chemical syntheses within the Process Chemistry R&D departments of GlaxoSmithKline, AstraZeneca and Pfizer.

[1]  Ivan Marziano,et al.  Critical assessment of pharmaceutical processes--A rationale for changing the synthetic route. , 2006, Chemical reviews.

[2]  F. Buono,et al.  Oxidative dehydrogenation of dihydropyrimidinones and dihydropyrimidines. , 2005, Organic letters.

[3]  J. Mitchell,et al.  A comparison of catalysts to promote imidazolide couplings including the identification of 2-hydroxy-5-nitropyridine as a new, safe, and effective catalyst , 2005 .

[4]  E. Plettner,et al.  2-Chlorobicyclo[2.2.1]hept-5-ene-2-carboxamide and 2-chlorobicyclo[2.2.1]heptane-2-carboxamide as precursors of bicyclo[2.2.1]hept-5-en-2-one and bicyclo[2.2.1]heptan-2-one: resolution, absolute configuration and hydrogen-bonding properties , 2005 .

[5]  R. Sheldon.  Green solvents for sustainable organic synthesis: state of the art , 2005 .

[6]  I. Appleby,et al.  Efficient synthesis of an imidazole-substituted delta-amino acid by the integration of chiral technologies. , 2005, Organic letters.

[7]  D. Ripin,et al.  Survey of GMP Bulk Reactions Run in a Research Facility between 1985 and 2002 , 2005 .

[8]  M. Dekhane,et al.  Successful Development and Scale-up of a Palladium-Catalysed Amination Process in the Manufacture of ZM549865 , 2004 .

[9]  K. Prasad,et al.  The Art of Meeting Palladium Specifications in Active Pharmaceutical Ingredients Produced by Pd-Catalyzed Reactions , 2004 .

[10]  Björn Gregertsen,et al.  Development of a Manufacturing Process for Sibenadet Hydrochloride, the Active Ingredient of Viozan , 2004 .

[11]  J. Bien,et al.  Removal of Metals from Process Streams: Methodologies and Applications , 2004 .

[12]  A. Borghese,et al.  Efficient Fast Screening Methodology for Optical Resolution Agents: Solvent Effects Are Used To Affect the Efficiency of the Resolution Process , 2004 .

[13]  Bernhard Hauer,et al.  Industrial methods for the production of optically active intermediates. , 2004, Angewandte Chemie.

[14]  D. Ripin,et al.  2-Methyltetrahydrofuran as an alternative to dichloromethane in 2-phase reactions , 2003 .

[15]  N. Simpkins,et al.  Application of the chiral base desymmetrisation of imides to the synthesis of the alkaloid jamtine and the antidepressant paroxetine , 2003 .

[16]  Gary Francis GlaxoSmithKline Breen,et al.  The Development of a Manufacturing Route for the GPIIb/IIIa Receptor Antagonist SB-214857-A. Part 2: Conversion of the Key Intermediate SB-235349 to SB-214857-A , 2003 .

[17]  Gary Francis GlaxoSmithKline Breen,et al.  The Development of a Manufacturing Route for the GPIIb/IIIa Receptor Antagonist SB-214857-A. Part 1: Synthesis of the Key Intermediate 2,3,4,5-Tetrahydro-4-methyl-3-oxo-1H-1,4-benzodiazepine-2-acetic Acid Methyl Ester, SB-235349 , 2003 .

[18]  David J. C. Constable,et al.  Metrics to ‘green’ chemistry—which are the best? , 2002 .

[19]  B. Kaptein,et al.  The role of nucleation inhibition in optical resolutions with families of resolving agents. , 2002, Angewandte Chemie.

[20]  E. Negishi.  Handbook of organopalladium chemistry for organic synthesis , 2002 .

[21]  G. Webb,et al.  Enantioselective synthesis of (S)-salmeterol via asymmetric reduction of azidoketone by Pichia angusta , 2001 .

[22]  Gary Francis GlaxoSmithKline Breen,et al.  A new synthesis of the GPIIb/IIIa receptor antagonist SB-214857-A , 2001 .

[23]  Hanna Cotton,et al.  Asymmetric synthesis of esomeprazole , 2000 .

[24]  M. Mitchell,et al.  Application of Automation and Thermal Analysis to Resolving Agent Selection , 1999 .

[25]  K. Erhard,et al.  Enantiospecific synthesis of SB 214857, a potent, orally active, nonpeptide fibrinogen receptor antagonist , 1995 .

[26]  S. Buchwald,et al.  Industrial-Scale Palladium-Catalyzed Coupling of Aryl Halides and Amines –A Personal Account , 2006 .

[27]  S. Buchwald,et al.  Practical Palladium Catalysts for C-N and C-O Bond Formation , 2002 .

[28]  A. Pettman,et al.  Process Development of Voriconazole: A Novel Broad-Spectrum Triazole Antifungal Agent , 2001 .

[29]  J. R. Hanson,et al.  Protecting Groups in Organic Synthesis , 1999 .

[30]  S. Chou,et al.  SYNTHESIS OF 2-HYDROXYMETHYL-3,5-DIMETHYL-4-METHOXYPYRIDINE : A KEY INTERMEDIATE FOR OMEPRAZOLE , 1997 .

[31]  J. A. Barton,et al.  Bretherick's Handbook of Reactive Chemical Hazards , 1990 .

[32]  S. Ali,et al.  Tetrahedron , 1957, Nature.

[33]  Synlett , 2022 .